• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对同时感染艾滋病毒的内脏利什曼病患者生活质量的评估:印度比哈尔邦的一项比较研究。

Assessment of quality of life in visceral leishmaniasis patients coinfected with HIV: a comparative study in Bihar, India.

作者信息

Pund Ram, Vishwas Gopal, Madhukar Major, Pandey Krishna, Dhingra Sameer

机构信息

Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research (NIPER) Hajipur, Export Promotions Industrial Park (EPIP), Industrial Area, Hajipur, Dist., Vaishali, Bihar, 844102, India.

Department of Clinical Medicine, ICMR-Rajendra Memorial Research Institute of Medical Sciences, Agamkuan, Patna, Bihar, India.

出版信息

J Health Popul Nutr. 2025 Jun 3;44(1):183. doi: 10.1186/s41043-025-00821-6.

DOI:10.1186/s41043-025-00821-6
PMID:40462242
Abstract

BACKGROUND

This study was aimed to evaluates the quality of life using WHOQOL-BREF in VL patients co-infected with HIV in Bihar, India.

METHODS

This cross-sectional study enrolled 240 participants: 60 HIV-VL co-infected, 60 HIV, 60 VL and 60 healthy individuals. Socio-demographic data and QOL assessments used the Hindi WHOQOL-BREF questionnaire. The data were compared using the chi-square test, One-Way ANOVA followed by Tukey's post-hoc Test. Generalised linear regression was performed for analyses of predictors of QOL, as well as the socio-economic status was determined by using the Modified Kuppuswamy socio-economic Scale 2022.

RESULTS

HIV-VL co-infected patients reported significantly lower QOL scores across all domains (physical, psychological, social relationships, and environmental) compared to healthy individuals (p < 0.05). Notably, psychological (12.17 ± 1.17), social relationship (5.90 ± 1.16), and environmental (14.10 ± 1.68) domains were severely impacted in HIV-VL coinfection in contrast to HIV (p < 0.05) and VL (p < 0.05).

CONCLUSION

HIV-VL co-infection profoundly affects quality of life, emphasizing the need for targeted interventions addressing psychological, social and environmental well-being. Future research should prioritize strategies improving QOL and assessing long-term treatment effects in HIV-VL co-infection.

摘要

背景

本研究旨在使用世界卫生组织生活质量简表(WHOQOL - BREF)评估印度比哈尔邦同时感染艾滋病毒和内脏利什曼病(VL)患者的生活质量。

方法

这项横断面研究招募了240名参与者:60名艾滋病毒 - VL合并感染者、60名艾滋病毒感染者、60名利什曼病患者和60名健康个体。社会人口统计学数据和生活质量评估使用印地语版的WHOQOL - BREF问卷。数据采用卡方检验、单因素方差分析及随后的Tukey事后检验进行比较。进行广义线性回归分析生活质量的预测因素,并使用2022年改良库普苏瓦米社会经济量表确定社会经济地位。

结果

与健康个体相比,艾滋病毒 - VL合并感染患者在所有领域(身体、心理、社会关系和环境)的生活质量得分均显著较低(p < 0.05)。值得注意的是,与艾滋病毒感染(p < 0.05)和利什曼病感染(p < 0.05)相比,艾滋病毒 - VL合并感染对心理(12.17 ± 1.17)、社会关系(5.90 ± 1.16)和环境(14.10 ± 1.68)领域的影响更为严重。

结论

艾滋病毒 - VL合并感染对生活质量有深远影响,强调需要针对心理、社会和环境福祉进行有针对性的干预。未来的研究应优先考虑改善生活质量的策略,并评估艾滋病毒 - VL合并感染的长期治疗效果。

相似文献

1
Assessment of quality of life in visceral leishmaniasis patients coinfected with HIV: a comparative study in Bihar, India.对同时感染艾滋病毒的内脏利什曼病患者生活质量的评估:印度比哈尔邦的一项比较研究。
J Health Popul Nutr. 2025 Jun 3;44(1):183. doi: 10.1186/s41043-025-00821-6.
2
Health-related quality of life of HIV infected adults with and without Visceral Leishmaniasis in Northwest Ethiopia.埃塞俄比亚西北部感染和未感染内脏利什曼病的艾滋病毒感染成年人的健康相关生活质量。
Health Qual Life Outcomes. 2017 Aug 30;15(1):65. doi: 10.1186/s12955-017-0636-6.
3
Assessment of quality of life using WHOQOL-BREF in patients with visceral leishmaniasis.采用 WHOQOL-BREF 量表评估内脏利什曼病患者的生活质量。
Health Qual Life Outcomes. 2019 Mar 28;17(1):53. doi: 10.1186/s12955-019-1112-2.
4
Knowledge, attitude and practices towards visceral leishmaniasis among HIV patients: A cross-sectional study from Bihar, India.印度比哈尔邦 HIV 患者内脏利什曼病的知识、态度和实践:一项横断面研究。
PLoS One. 2021 Aug 17;16(8):e0256239. doi: 10.1371/journal.pone.0256239. eCollection 2021.
5
Knowledge, Attitude, and Practices among HIV/Leishmaniasis Co-Infected Patients in Bihar, India.印度比哈尔邦 HIV/利什曼病合并感染患者的知识、态度和实践。
Am J Trop Med Hyg. 2022 Aug 29;107(4):789-795. doi: 10.4269/ajtmh.21-1294. Print 2022 Oct 12.
6
Effect of Health Care on Quality of Life among Human Immunodeficiency Virus Infected Adults With and Without Visceral Leishmaniasis in northwest Ethiopia: A Longitudinal Follow-Up Study.埃塞俄比亚西北部感染人类免疫缺陷病毒的内脏利什曼病成人与非内脏利什曼病成人的医疗保健对生活质量的影响:一项纵向随访研究。
Am J Trop Med Hyg. 2018 Mar;98(3):747-752. doi: 10.4269/ajtmh.17-0458. Epub 2018 Jan 18.
7
Quality of life perceptions amongst patients co-infected with Visceral Leishmaniasis and HIV: A qualitative study from Bihar, India.利什曼原虫病和艾滋病毒合并感染患者的生活质量认知:来自印度比哈尔邦的一项定性研究。
PLoS One. 2020 Feb 10;15(2):e0227911. doi: 10.1371/journal.pone.0227911. eCollection 2020.
8
Visceral Leishmaniasis-HIV Coinfection as a Predictor of Increased Transmission at the Village Level in Bihar, India.内脏利什曼病-人类免疫缺陷病毒合并感染是印度比哈尔邦村庄层面传播增加的预测因素。
Front Cell Infect Microbiol. 2021 Mar 11;11:604117. doi: 10.3389/fcimb.2021.604117. eCollection 2021.
9
Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India.印度对合并感染人类免疫缺陷病毒的内脏利什曼病患者的联合治疗。
Clin Infect Dis. 2015 Oct 15;61(8):1255-62. doi: 10.1093/cid/civ530. Epub 2015 Jun 30.
10
Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.脂质体两性霉素 B 治疗人免疫缺陷病毒合并内脏利什曼病患者:印度比哈尔邦的 2 年治疗结局。
Clin Infect Dis. 2011 Oct;53(7):e91-8. doi: 10.1093/cid/cir521.

本文引用的文献

1
AmBisome Monotherapy and Combination AmBisome-Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial.印度 HIV 合并内脏利什曼病患者中两性霉素 B 脂质体单药治疗与两性霉素 B 脂质体-米替福新联合治疗的随机、开放标签、平行分组、3 期临床试验。
Clin Infect Dis. 2022 Oct 12;75(8):1423-1432. doi: 10.1093/cid/ciac127.
2
Quality of life perceptions amongst patients co-infected with Visceral Leishmaniasis and HIV: A qualitative study from Bihar, India.利什曼原虫病和艾滋病毒合并感染患者的生活质量认知:来自印度比哈尔邦的一项定性研究。
PLoS One. 2020 Feb 10;15(2):e0227911. doi: 10.1371/journal.pone.0227911. eCollection 2020.
3
Assessment of quality of life using WHOQOL-BREF in patients with visceral leishmaniasis.采用 WHOQOL-BREF 量表评估内脏利什曼病患者的生活质量。
Health Qual Life Outcomes. 2019 Mar 28;17(1):53. doi: 10.1186/s12955-019-1112-2.
4
Effect of Health Care on Quality of Life among Human Immunodeficiency Virus Infected Adults With and Without Visceral Leishmaniasis in northwest Ethiopia: A Longitudinal Follow-Up Study.埃塞俄比亚西北部感染人类免疫缺陷病毒的内脏利什曼病成人与非内脏利什曼病成人的医疗保健对生活质量的影响:一项纵向随访研究。
Am J Trop Med Hyg. 2018 Mar;98(3):747-752. doi: 10.4269/ajtmh.17-0458. Epub 2018 Jan 18.
5
Health-related quality of life of HIV infected adults with and without Visceral Leishmaniasis in Northwest Ethiopia.埃塞俄比亚西北部感染和未感染内脏利什曼病的艾滋病毒感染成年人的健康相关生活质量。
Health Qual Life Outcomes. 2017 Aug 30;15(1):65. doi: 10.1186/s12955-017-0636-6.
6
Epidemiology of intestinal helminthiasis among school children with emphasis on Schistosoma mansoni infection in Wolaita zone, Southern Ethiopia.埃塞俄比亚南部沃莱塔地区学童肠道蠕虫病流行病学,重点关注曼氏血吸虫感染情况
BMC Public Health. 2017 Jun 20;17(1):587. doi: 10.1186/s12889-017-4499-x.
7
Perceived quality of life among Visceral Leishmaniasis and HIV coinfected migrant male-workers in Northwest Ethiopia: a qualitative study.埃塞俄比亚西北部内脏利什曼病和艾滋病毒合并感染的流动男性工人的生活质量认知:一项定性研究。
BMC Public Health. 2017 Feb 16;17(1):204. doi: 10.1186/s12889-017-4132-z.
8
Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India.印度对合并感染人类免疫缺陷病毒的内脏利什曼病患者的联合治疗。
Clin Infect Dis. 2015 Oct 15;61(8):1255-62. doi: 10.1093/cid/civ530. Epub 2015 Jun 30.
9
WHOQOL-BREF Hindi questionnaire: Quality of life assessment in acetabular fracture patients.世界卫生组织生活质量简表(WHOQOL - BREF)印地语问卷:髋臼骨折患者的生活质量评估
Indian J Orthop. 2015 May-Jun;49(3):323-8. doi: 10.4103/0019-5413.156206.
10
Quality of life among people living with hypertension in a rural Vietnam community.越南农村社区高血压患者的生活质量
BMC Public Health. 2014 Aug 11;14:833. doi: 10.1186/1471-2458-14-833.